Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
WNT5a/GSK3/β-Catenin Control of Muscle FAP Adipogenesis
2026-08-16
The reference study identifies the WNT5a/GSK3/β-catenin axis as a regulatory circuit that restrains adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, mass cytometry, network modeling, and transcriptomic datasets, the authors connect β-catenin stability with muscle fat infiltration and FAP support of satellite-cell differentiation.
-
M344 Histone Deacetylase Inhibitor Workflow
2026-08-15
M344 is a cell-permeable histone deacetylase inhibitor for connecting histone acetylation with proliferation, differentiation, radiation response, and viral-latency assays. This practical guide covers dose selection, time-resolved readouts, formulation, and troubleshooting across breast cancer, neuroblastoma, medulloblastoma, and ex vivo models.
-
Captopril: ACE Inhibition Workflows for Research
2026-08-14
Captopril supports controlled ACE inhibition in hypertension research while offering a practical way to probe bradykinin-linked gastrointestinal signaling. This guide connects biochemical, isolated-tissue, and cancer-model workflows with preparation guidance, controls, and troubleshooting boundaries.
-
Sunitinib Workflows for RCC Angiogenesis Research
2026-08-14
Build reproducible Sunitinib assays for RTK signaling, tumor angiogenesis, apoptosis, and drug-resistance research. This workflow also shows how to test combination strategies, including the EGFR/PI3K/Akt-focused approach reported for syringin in renal cell carcinoma models.
-
Q-VD(OMe)-OPh in Cell Death Pathway Mapping
2026-08-13
Q-VD(OMe)-OPh provides a rigorous way to separate caspase-dependent apoptosis from ferroptosis and autophagy in complex cell-death assays. This article translates findings from a cetuximab-resistance study into practical experimental decisions for cancer biology, apoptosis assay design, and pathway validation.
-
Fingolimod (FTY720): A Trafficking-to-Assay Guide
2026-08-13
Fingolimod (FTY720) is more than an oral multiple sclerosis therapy: it is a powerful tool for dissecting S1P-controlled immune-cell trafficking, CNS signaling, and assay interpretation. This guide connects its mechanism with lessons from magnetic CAR-T-mimicking cell research while clearly separating established evidence from experimental opportunities.
-
Fluo-4 AM Calcium Assay Kit for Mechanotransduction
2026-08-12
Use the Fluo-4 AM Calcium Assay Kit to connect scaffold mechanics with live intracellular calcium detection in annulus fibrosus cells. Its 488 nm-compatible, no-wash workflow also supports scalable GPCR inhibitor screening and GPCR agonist screening when kinetic signal quality and cell viability matter.
-
Pexmetinib (ARRY-614): A State-Aware Assay Guide
2026-08-12
Pexmetinib (ARRY-614) is a dual kinase probe for connecting cytokine output with p38 MAPK and Tie2 pathway behavior. This guide explains how recent structural findings on p38α dephosphorylation can improve assay design, interpretation, and translational relevance.
-
Annexin V-Cy5 Apoptosis Kit for Microglia
2026-08-11
Use rapid phosphatidylserine labeling to separate genuine cell death from lysosomal stress in microglia and other experimental systems. The Annexin V-Cy5 Apoptosis Kit supports complementary flow cytometry and fluorescence microscopy workflows, helping researchers validate whether a treatment changes apoptosis, clearance, or intracellular digestion.
-
Annexin V-Cy5 Apoptosis Kit for Microglia
2026-08-11
The Annexin V-Cy5 Apoptosis Kit provides a rapid way to separate phosphatidylserine exposure from lysosomal stress in microglial models. This article translates a reversible zebrafish microglia study into practical microscopy and flow cytometry apoptosis detection workflows, with optimization guidance for difficult samples.
-
Platanoside, Ferroptosis, and Acute Lung Injury
2026-08-10
The reference study identifies an autophagy-dependent Keap1 degradation mechanism through which platanoside activates the Nrf2/GPX4 antioxidant axis and suppresses ferroptosis in lipopolysaccharide-induced acute lung injury. Its findings connect Keap1–p62 complex formation with reduced lipid peroxidation, mitochondrial damage, inflammation, and histological injury, while also highlighting the need for broader causal validation.
-
Annexin V-Cy5 Apoptosis Kit Workflow
2026-08-09
Build a rapid Annexin V apoptosis detection workflow for distinguishing apoptotic signaling from lysosomal stress, with microscopy and flow cytometry options. The Annexin V-Cy5 Apoptosis Kit provides a practical complement to microglial imaging, phagocytosis, and transcriptomic assays in reversible neuroimmune-stress models.
-
ARCA EGFP mRNA for Reliable Cell Assays
2026-08-08
Learn how ARCA EGFP mRNA (SKU R1001) functions as a direct fluorescence reporter for separating transfection performance from cell viability and cytotoxicity results. This scenario-based guide covers reporter selection, handling, optimization, and interpretation in mammalian cell workflows.
-
CTP Solution for Reliable mRNA Synthesis
2026-08-07
CTP Solution (100 mM) provides a defined, nuclease-free nucleotide input for in vitro transcription workflows that support engineered mRNA and lipid nanoparticle studies. This article connects upstream Cytidine-5'-triphosphate control with the localized p21 mRNA–LNP strategy reported for bladder cancer, while separating documented findings from practical pilot recommendations.
-
Protease Inhibitor Cocktail (EDTA-Free): Precision for OXPHO
2026-08-07
Explore how the Protease Inhibitor Cocktail (EDTA-Free) uniquely supports high-fidelity OXPHOS assays and advanced protein stability work. This article offers a deep, scientific perspective on protease inhibition in mitochondrial research, bridging mechanistic insight and cutting-edge practical applications.